Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
Apply
Zanzalintinib & Pembrolizumab
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step